Background illustration for clinical trials search

Paid Clinical Trials New Mexico

Discover 332 paid clinical trials in New Mexico. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

for
CRC (Colorectal Cancer)
Location: Levis, Shirley NY, Morristown NJ, Doylestown PA,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07284849

Phase 3, Recruiting

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

for
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic,
Location: Worcester MA, Quebec, White Plains NY, The Bronx NY,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07144280

Phase 3, Recruiting

A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study

for
Hematopoietic and Lymphatic System Neoplasm,
Location: New Haven CT, The Bronx NY, Brooklyn NY, Hackensack NJ,
Sponsor: Children's Oncology Group

Sex: All

Age: 15 - 20

Code: NCT06410209

Phase 2, Recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

for
Advanced Malignant Solid Neoplasm,
Location: Brewer ME, Augusta ME, Scarborough ME,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0+

Code: NCT05564377

Phase 2, Recruiting

Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers

for
Metastatic Salivary Gland Carcinoma,
Location: Boston MA, Lebanon NH, Commack NY, Uniondale NY,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT05408845

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

for
Atrial Fibrillation
Location: Scarborough ME, Boston MA, Providence RI, Burlington MA,
Sponsor: Johns Hopkins University

Sex: All

Age: 22 - 70+

Code: NCT05836987

Phase 3, Recruiting

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

for
Prediabetic State, Atherosclerosis, Metformin
Location: Boston MA, West Haven CT, New York NY, Baltimore MD,
Sponsor: VA Office of Research and Development

Sex: All

Age: 18+

Code: NCT02915198

Recruiting

The Fourth Left Atrial Appendage Occlusion Study

for
Atrial Fibrillation, Stroke, Ischemic, Systemic Embolism
Location: Providence RI, Burlington MA, Quebec, Sherbrooke,
Sponsor: Hamilton Health Sciences Corporation

Sex: All

Age: 18+

Code: NCT05963698

Recruiting

Targeted TDCS to Enhance Speech-Language Treatment Outcome in Persons With Chronic Post-Stroke Aphasia.

for
Stroke, Aphasia
Location: Albuquerque NM
Sponsor: University of New Mexico

Sex: All

Age: 25 - 70+

Code: NCT04432883

Recruiting

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: Saint Johnsbury VT, Lebanon NH, Lake Success NY,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT04510597

Phase 3, Recruiting

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

for
End Stage Kidney Disease
Location: Halifax, Portsmouth NH, Boston MA, East Providence RI,
Sponsor: CSL Behring

Sex: All

Age: 18+

Code: NCT05485961

Phase 2, Phase 3, Recruiting

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

for
Cutaneous Melanoma, Stage II
Location: Guilford CT, New Haven CT, Quebec City, Bay Shore NY,
Sponsor: Melanoma and Skin Cancer Trials Limited

Sex: All

Age: 18+

Code: NCT03860883

Recruiting

Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias

for
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation,
Location: Portland ME, Boston MA, New York NY, Poughkeepsie NY,
Sponsor: Heart Rhythm Clinical and Research Solutions, LLC

Sex: All

Age: 18+

Code: NCT04088071

Recruiting

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia,
Location: Halifax, Portland ME, Scarborough ME, South Portland ME,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT05554406

Phase 2, Recruiting

Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System

for
Pulmonary Embolism
Location: Fall River MA, Boston MA, Providence RI, Roslyn NY,
Sponsor: Penumbra Inc.

Sex: All

Age: 18+

Code: NCT04798261

Recruiting

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

for
Psoriatic Arthritis
Location: Brooklyn NY, Wyomissing PA, Hagerstown MD,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06671483

Phase 3, Recruiting

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for
Acute Coronary Syndrome
Location: Halifax, Moncton, Bangor ME, Rimouski, Providence RI,
Sponsor: DalCor Pharmaceuticals

Sex: All

Age: 45+

Code: NCT05918861

Phase 3, Recruiting

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

for
Endometrial Cancer, Gastric Cancer,
Location: Commack NY, East Brunswick NJ, Columbus OH,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT05489211

Phase 2, Recruiting

Study of Olverembatinib (HQP1351) in Patients With CML-CP

for
Chronic Myeloid Leukemia, CML, CML, Chronic Phase
Location: Shirley NY, Hackensack NJ, New Brunswick NJ,
Sponsor: Ascentage Pharma Group Inc.

Sex: All

Age: 18+

Code: NCT06423911

Phase 3, Recruiting

Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy

for
Malignant Solid Neoplasm
Location: Providence RI, New Haven CT, Lebanon NH, Fairfield CT,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05642611

Phase 3, Recruiting

Popular cities in New Mexico

Las CrucesSanta FeAlbuquerque